Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs7208889 | chr17:59495553 | C/T | 6.07E-7 | 178 | 25.67 | 24.5 | 9.6 | KM Plot |
PCPG | rs72129796 | chr14:74502559 | TCACA/T | 0.000221 | 175 | 25.4 | 27.43 | 10.43 | KM Plot |
PCPG | rs72151676 | chr13:37551950 | AAC/A | 0.000327 | 176 | 4.17 | 24.17 | 25.87 | KM Plot |
PCPG | rs7215188 | chr17:80509479 | C/T | 4.21E-5 | 178 | 25.97 | 19.72 | 7.2 | KM Plot |
PCPG | rs7224708 | chr17:75782839 | A/G | 0.000194 | 178 | 16.18 | 27.27 | 25.4 | KM Plot |
PCPG | rs7244542 | chr18:74544977 | C/T | 4.53E-9 | 178 | 25.6 | 25.52 | 10.17 | KM Plot |
PCPG | rs7247294 | chr19:29279929 | A/G | 0.000475 | 172 | 26.57 | 20.37 | 11.22 | KM Plot |
PCPG | rs72477006 | chr16:89950299 | G/C | 0.000205 | 174 | 25.6 | 22.63 | 3.17 | KM Plot |
PCPG | rs72477008 | chr16:90074356 | G/C | 8.43E-9 | 176 | 25.92 | 20.28 | 6.62 | KM Plot |
PCPG | rs72526691 | chr16:1695056 | T/TAC | 4.76E-5 | 176 | 24.85 | 30.25 | 19.83 | KM Plot |
PCPG | rs72631328 | chr17:65794705 | G/A | 0.000472 | 176 | 24.5 | 36 | 8.22 | KM Plot |
PCPG | rs72640848 | chr8:53836225 | A/G | 0.000375 | 175 | 24.7 | 27.33 | 6.1 | KM Plot |
PCPG | rs72640849 | chr8:53836430 | A/T | 0.00039 | 175 | 24.7 | 27.2 | 6.1 | KM Plot |
PCPG | rs72640850 | chr8:53836681 | A/C | 0.000414 | 174 | 24.47 | 27.2 | 6.1 | KM Plot |
PCPG | rs72640852 | chr8:53838084 | G/A | 0.000429 | 173 | 24.7 | 27.2 | 6.1 | KM Plot |